Position in ARGX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$89,540,010
+$37,316,912 QoQ
Shares Held
96,511
+35.0% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
2.25%
of 13F equity value
Holder Rank
#42
of 505 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PGGM Investments holds $147,269,837 across 2 Biotechnology names. ARGX ranks #1 (60.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
This page
|
96,511 | $89,540,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
92,584 | $57,729,827 |
All Filings in ARGX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $89,540,010 | 96,511 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $52,223,098 | 71,514 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $46,109,288 | 54,830 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $56,570,114 | 76,699 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $42,278,022 | 76,699 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $28,882,420 | 48,799 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $34,914,165 | 56,771 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $34,914,830 | 64,409 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $27,698,446 | 64,409 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $17,554,399 | 44,586 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $16,961,851 | 44,586 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $21,919,815 | 44,586 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $17,376,501 | 44,586 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $16,611,851 | 44,586 | Shares | Sole | 2023-05-11 | |
| No filing history on record for this holder in this stock. | ||||||